Clinical Trials in Pittsburgh

Showing 1041-1060 of 10,050 trials

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

NCT05867420

The study is a dose-escalation and dose-expansion study to evaluate the safety, tolerability, and pharmacokinetics of ASKG915 as a single agent or in combination with standard of care (SOC) in patients with selected types of advanced solid tumors.

Advanced Solid Tumors

AskGene Pharma, Inc.594 participantsStarted Aug 2023

New York, New York, United States • Pittsburgh, Pennsylvania, United States • Beijing, Beijing Municipality, China +1 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

NCT03432286

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.

Episodic Migraine

Eli Lilly and Company533 participantsStarted Mar 2018

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +70 more locations

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Find Trials by Condition in Pittsburgh

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Social & Contextual Impact on Children Undergoing Liver Transplantation

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Vaccine Immune Recovery After Leukemia

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery